Figure 9
Organ mass measured by the end of dosing period and recovery period. (A) Absolute organ mass by end of dosing period. (B) Relative organ mass by end of dosing period. (C) Absolute organ mass by end of recovery period. (D) Relative organ mass by end of recovery period. Data are presented as means ± SD (n = 6 monkeys/group in treatment period; n = 4/group for recovery period). *P < 0.05, **P < 0.01. *represents significant difference compared to Control group and Low-dose group.
